Last summer, the Food and Drug Administration denied an application for a new antifungal drug called olorofim, sending it back to the company with a request for more data. If approved, it would have ...
(Reuters) - F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop treatments for ...
Amebiasis is a parasitic disease caused by the microscopic protozoan Entamoeba histolytica. Infection occurs through the ...
Systemic candidiasis is an opportunistic fungal infection that has been difficult to treat effectively. Research published in ...
Professors Elaine Bignell and Neil A.R. Gow address the threat of fungal infections, highlighting the sharp rise in ...
Please provide your email address to receive an email when new articles are posted on . Providers treating patients with antifungals reported a moderate-to-high percentage of any therapeutic drug ...
Patients taking Tibsovo to treat MDS or AML may want to discuss the appropriate medications to treat and prevent infections, an expert said. Tibsovo (ivosidenib), which is used to treat patients with ...
Still dealing with itchy, scaly feet months (or even years) after National Service? Experts explain why athlete’s foot ...
On September 26, 2023, the U.S. Environmental Protection Agency (EPA) requested comment on a proposed framework to strengthen the assessment of antimicrobial-resistance risks associated with pesticide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results